Projects per year
Personal profile
Research expertise
Eric Florence graduated as medical doctor from the Université Catholique de Louvain in 1996.
After a postgraduate in tropical medicine at the Institute of Tropical Medicine he worked with Médecins sans Frontières in Kenya. In 2001 and 2002, he carried out short time consultancy missions for the German Cooperation Agency (GTZ) and the Ministry of Health in Kinshasa and Kigali working on availibility of antiretroviral drugs in resource limited settings. In 2003 he collaborated with the Department of Infectious Diseases, Hospital Clínic in Barcelona on immuno-pathology of HIV infection and immune-based therapies.
He obtained his PhD in Medical Sciences in 2004 at the University of Antwerp and Institute of Tropical Medicine (Doctoral thesis "Antiretroviral treatment in HIV infected adults: current drawbacks and pitfalls" promotor: R. Colebunders). He specialised further in Internal Medecine and Intensive Care at the University of Antwerp.
Eric Florence is responsible for the HIV/STD outpatient department of the Institute of Tropical Medicine since June 2008.
Research themes
- Side effects of antiretroviral treatments
- Clinical trial of HIV infection
- Cordination and supervision of the clinical research activities at the HIV/STD outpatient department.
Education/Academic qualification
Doctor
PhD
External positions
Attending physician, Antwerp University Hospital
1-Oct-2006 → …Fingerprint
Dive into the research topics where Eric Florence is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
PRESTIP: PReventing the Emergence of untreatable STIs via radical Prevention
Kenyon, C., Crucitti, T., De Baetselier, I., Florence, E., Soentjens, P., Basil, S. S. & Van Wymeersch, K.
Flemish Government - Department of Economy, Science & Innovation
1/01/21 → 31/12/24
Project: Research Project
-
DAA_HepC_HIV_MS: Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSM
Hens, N., Robaeys, G., Vandamme, A., Nevens, F., Van Wijngaerden, E., De Wit, S., Buvé, A., Van Aerde, K., Florence, E. & Ratsarahery, L.
Fonds voor Wetenschappelijk Onderzoek
1/01/17 → 31/12/22
Project: Research Project
-
CHEMIFIED: Ontwikkeling en evaluatie van een gecomputeriseerde interventie voor chemsex ondersteuning
Florence, E. & Van Wymeersch, K.
19/11/20 → 31/12/21
Project: Research Project
-
CHEMIFIED+: Chemified: pilot testing of a mobile application for chemsexcare and support
Florence, E., Platteau, T. & Van Wymeersch, K.
20/10/20 → 20/10/21
Project: Research Project
Research output
-
A public health value-based healthcare paradigm for HIV
Vermeersch, S., Demeester, R. P., Ausselet, N., Callens, S., De Munter, P., Florence, E., Goffard, J-C., Henrard, S., Lacor, P., Messiaen, P., Libois, A., Seyler, L., Uurlings, F., Vandecasteele, S. J., Van Wijngaerden, E., Yombi, J-C., Annemans, L. & De Wit, S., 2022, In : BMC Health Services Research. 22, 1, p. 1-11 11 p., 13.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile2 Downloads (Pure) -
Seroconversion and antibody persistence after yellow fever vaccination in people living with HIV: impact of baseline HIV viral load and yellow fever seropositivity
Martin, C., Florence, E., Domingo, C., Delforge, M., De Wit, S. & Dauby, N., 2022, In : Journal of Travel Medicine.Research output: Contribution to journal › A1: Web of Science-article
-
Why do HIV pre-exposure prophylaxis users discontinue pre-exposure prophylaxis care? A mixed methods survey in a pre-exposure prophylaxis clinic in Belgium
Vanbaelen, T., Rotsaert, A., Jacobs, B. K. M., Florence, E., Kenyon, C., Vuylsteke, B., Laga, M. & Reyniers, T., 2022, In : AIDS Patient Care and STDs. 36, 4, p. 159-167 9 p.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile -
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial
Van Dijck, C., Tsoumanis, A., Rotsaert, A., Vuylsteke, B., Van den Bossche, D., Paeleman, E., De Baetselier, I., Brosius, I., Laumen, J., Buyze, J., Wouters, K., Lynen, L., Van Esbroeck, M., Herssens, N., Abdellati, S., Declercq, S., Reyniers, T., Van Herrewege, Y., Florence, E. & Kenyon, C., 2021, In : Lancet Infectious Diseases. 21, 5, p. 657-667 11 p.Research output: Contribution to journal › A1: Web of Science-article
-
Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL): examining health care staff attitudes during a hybrid III implementation-effectiveness trial implementing cabotegravir plus rilpivirine long-acting injectable (CAB plus RPV LA) for people living with HIV (PLHIV)
Gutner, C., Dakhia, S., Gill, M., Pascual-Bernaldez, M., Hernandez, B., Rami, A., Portilla, J., Lutz, T., van der Valk, M., Florence, E., Barnes, N., Cooper, O., Filipenko, D., Hamilton, A., Bosse, M. & Czarnogorski, M., 2021, In : HIV Medicine. 22, p. 114-115 2 p.Research output: Contribution to journal › Conference abstract in journal